XML 52 R39.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of activity under the stock option plans
   2010 Plan   2017 Plan   Weighted Average Exercise Price   Aggregate Intrinsic Value(1) 
Outstanding as of December 31, 2019   255,000    133,500   $6.48   $(516,475)
Grants   7,000    93,000   $5.03      
Terminations/forfeitures   (12,000)   (50,000)  $5.45      
Exercises   (12,500)   
   $3.15      
Outstanding as of December 31, 2020   237,500    176,500   $6.38   $(180,038)
Grants   
    86,000   $9.78      
Terminations/forfeitures   (12,000)   (20,000)  $7.26      
Exercises   (7,000)   (18,000)  $7.08      
Outstanding as of December 31, 2021   218,500    224,500   $6.94   $468,425 
Vested as of December 31, 2021   184,500    98,500   $6.78   $345,350 
Vested and expected to vest as of December 31, 2021   218,500    224,500   $6.94   $468,425 
Reserved for future grants   
    57,500           

 

Schedule of additional information about the stock option plans
   Number of Shares   Weighted Average
Fair Value at Grant Date
   Weighted Average Exercise Price 
Non-vested stock options as of January 1, 2021   248,000   $3.25   $6.44 
Non-vested stock options as of December 31, 2021   160,000   $3.36   $7.23 
Stock options granted during the year ended December 31, 2021   86,000   $4.51   $9.78 
Stock options that vested during the year ended December 31, 2021   147,000   $3.74   $7.33 
Stock options that were forfeited during the year ended December 31, 2021   32,000   $3.81   $7.26 

 

Schedule of fair value stock option grant using black-scholes option valuation model with the weighted-average assumptions
  

During the Years
Ended December 31,

 
   2021   2020 
Risk-free interest rate   0.86%   0.41%
Dividend yield   0%   0%
Expected volatility   54%   53%
Expected life   5.0 years    6.1 years